Vaxart Announces Presentations at the Jefferies Virtual London Healthcare Conference & the Piper Sandler Annual Healthcare ConferenceGlobeNewsWire • 11/16/20
Vaxart Reports Third Quarter 2020 Financial Results and Provides Business UpdateGlobeNewsWire • 11/12/20
Vaxart Reports More Positive Data From Animal Testing of Its Coronavirus Vaccine CandidateThe Motley Fool • 11/12/20
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vaxart, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 10/23/20
VXRT Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Vaxart, Inc. Investors With Losses Exceeding $500K of Class Action and Lead Plaintiff Deadline: October 23, 2020Newsfile Corp • 10/23/20
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Vaxart, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 23, 2020 - VXRTNewsfile Corp • 10/22/20
VXRT FINAL DEADLINE NOTICE: ROSEN, TRUSTED AND TOP RANKED INVESTOR COUNSEL, Reminds Vaxart, Inc. Investors of Important Friday Deadline in Securities Class Action - VXRTPRNewsWire • 10/22/20
VXRT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 23, 2020 in the Class Action Filed on Behalf of Vaxart, Inc. Limited ShareholdersNewsfile Corp • 10/22/20
VXRT Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Vaxart, Inc. Investors With Losses Exceeding $500K of Class Action and Lead Plaintiff Deadline: October 23, 2020Business Wire • 10/22/20